Edward Keller to launch CRO business in Korea.

Published: 2004-02-26 06:56:00

Updated: 2004-02-26 06:56:00

Edward Keller, a Korea branch of the multinational commercial company named Diethelm Keller Siber Hegner, started a CRO business in Korea. The company has mainly engaged in the toxicology and clinical research for agricultural chemicals but now turned it to the pharmaceutical industry.

E. Kell...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK